Type (3 transforming growth factor (TGF-fi), a factor produced by many cell types, is a potent inhibitor of hepatocyte DNA synthesis in vitro. To determine whether TGF-fi can influence hepatocyte proliferation in vivo, its effects were examined on the regenerative response of liver to partial hepatectomy (PH) in the rat. Porcine platelet-derived (19, 20) .
duced a similar effect. A single dose of 0.5 lag of TGF-(81 given 11 hr after PH reduced liver [3H]thymidine incorporation by 32%; 4.5 pig of TGF-fi1 or TGF-fi2 inhibited DNA synthesis by 88% and the labeling index by 86%. Although sensitive to TGF-fi administered 11 hr after PH, late in the G1 phase of the cell cycle, a single dose of 0.5 pg given at the time of PH did not significantly influence DNA synthesis 22 hr after PH. The inhibitory effects of TGF-fl were transient; rats treated with two 0.5-pzg doses of TGF-13 at 0 and 11 hr had completely restored their original liver DNA mass 8 days after PH.
Administration of 0.5 pzg ofeither TGF-fi1 or TGF-.82 every 12 hr for 5 days failed to suppress the recovery of hepatic DNA mass. However, the nuclear labeling index of the TGF-ptreated animals was significantly higher than that of the controls. There was no evidence of cytotoxicity from TGF-fi, as determined by liver histology and plasma concentrations of glucose, insulin-like growth factor I, and two hepatic enzymes. Thus, TGF-(81 and TGF-(32 reversibly inhibit the proliferative response ofliver to PH and may be important in the modulation of normal liver growth and repair.
Type (B transforming growth factor (TGF-,3) was initially identified in culture medium conditioned by transformed cells and was named for its ability to induce a transformed phenotype in rodent fibroblasts (1, 2) , but this homodimer is also produced by normal cells (for review, see ref. 3) and is a potent growth inhibitor for cultured cells of epithelial origin, including hepatocytes (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) . Subpicomolar concentrations of TGF-,3 inhibit DNA synthesis stimulated by epidermal growth factor and other growth factors in primary cultures of adult rat (10) (11) (12) (13) and human fetal (14) hepatocytes and in lines of normal, but not of transformed, diploid rat liver epithelial cells (12, 15) .
In addition to the potent effects of TGF-p8 on liver-derived cells in culture, the liver has been demonstrated to be a major site of TGF-/3 metabolism in vivo. After an intravenous injection of 125I-labeled TGF-,B, Coffey et al. (16) (10) .
To test the hypothesis that TGF-,B can regulate liver growth in vivo, we studied its effects on the proliferative response of rat liver to partial hepatectomy. After experimental ablation of part of its mass, the liver remnant remains mitotically quiescent for [12] [13] [14] [15] [16] hr before it undergoes a rapid increase in DNA synthesis (17, 18) . The first, and most synchronized, wave of DNA synthesis occurs between 20 and 24 hr after partial hepatectomy; mitosis begins ==6 hr later and peaks at 30 hr. The original DNA content of the regenerating remnant is generally restored within 96 hr after a 69o hepatectomy (19, 20) .
We studied the effect of intravenous porcine plateletderived TGF-f3, in amounts calculated to saturate hepatic TGF-,8 receptors, on the rate of DNA synthesis and the regeneration of liver mass induced by partial hepatectomy in the rat. We also studied the effects of TGF-,8 on liver morphology and blood concentrations of several liverderived or regulated substances.
MATERIALS AND METHODS
Partial Hepatectomy. Male Sprague-Dawley rats (Holtzman, Madison, WI) weighing 182 + 14 g (mean ± SD) were given free access to water and a complete liquid diet (Dyets, Bethlehem, PA). They were individually housed under controlled lighting (lights on 0600-1800 hr). Normal weight gain and stable food intake were documented before study. Because of the striking diurnal variation in liver DNA synthesis after partial hepatectomy documented by Barbiroli and Potter (21) , all rats underwent partial hepatectomy (PH) or sham hepatectomy between 1100 and 1500 hr. PH consisted of excision of the median and left lateral lobes, which comprise 69.2% ± 0.6% of the total liver weight (19, 20) . To control for the nutritional effects of PH, the group of sham-operated animals was pair fed with the PH group. In the 22 hr following the operation, PH rats consumed 13.7 ± 9.3 kcal (1 cal = 4.18 J), compared with 52.4 ± 9.3 kcal in the 24 hr preceding PH. Sham hepatectomy consisted of liver manipulation without ablation; sham hepatectomy animals were allowed a total of 14 kcal in the 22 hr after operation.
Proc. Natl. Acad. Sci. USA 85 (1988) 5127 HCl buffer (0.5 ml) was injected into control rats at the same times.
Hepatic DNA Synthesis. Liver DNA synthesis was measured after injection of 50 or 100 ,uCi of [methyl-3H]thymidine (New England Nuclear; 6.7 Ci/mmol; 1 Ci = 37 GBq), as indicated, in 0.5 ml of 0.9% NaCl into a tail vein 20 hr after the operation (t = 20 hr). At 22 hr, the liver remnant was excised and portions were fixed in neutral buffered formalin for autoradiography or were homogenized in 5% trichloroacetic acid. The DNA content and radioactivity of the homogenized liver remnants were determined as described (19) . Liver DNA synthesis is expressed as cpm per ,g of DNA (mean ± SD). Autoradiographs were prepared from 6-tkm sections, which were exposed at 4°C for 6 weeks.
Nuclear labeling indices were determined from counts of =1500 nuclei per liver.
Extent of Liver Regeneration. In another group of rats, the weight and DNA content (,ug/g) of the liver lobes excised at the time of PH were measured (19 differences were detected between the inhibitory effects of TGF-P1 and TGF-,B2.
The histological and functional data suggest that the inhibitory effects ofTGF-/3 on hepatocyte DNA synthesis did not result from toxic actions of the peptide or from a generalized inhibitory effect on cellular synthetic function. Light microscopic examination of the livers revealed no significant differences among any of the treatment groups ( Fig. 2 C-F (Tables 2 and   3 ). Sham hepatectomy rats that were treated with 0.5 pug of TGF-,B1 at 0 and 11 hr showed a statistically significant, but small, increase in plasma glucose when compared to controls, but this effect was not evident in rats treated with 0.5 ,ug of TGF-13 every 12 hr for 5 days (Table 3) or with 4.5 Ag of TGF-31 or TGF-,32 at 11 hr (data not shown). TGF-f3 had no influence on circulating IGF-I, 85% of which is thought to be of liver origin (25) .
In a number of epithelial cell systems studied in vitro, the inhibitory effects of TGF-/3 have been reversible (5, 6) . In addition, TGF-P is cleared rapidly from the bloodstream: Coffey et al. (16) showed a serum tl12 of 4 min after PH and only 2.2 min in intact animals. Despite a 50% reduction in DNA synthesis at the normal peak period, the inhibitory (26) and bone (27) . Recently, at least two forms of TGF-f3 have been detected in porcine platelets (23) . TGF-f31 is identical to the only species of TGF-j3 found in human platelets, while TGF-f32, which was originally discovered by Holley and colleagues (28) as the growth inhibitor produced by BSC-1 cells at confluence, has been described in porcine platelets and bovine bone. TGF-,B2 does, however, appear to bind to the same cell-surface receptor as TGF-,81 and has generally similar biological activities (4, 23). TGF-,B can have both stimulatory and inhibitory effects on cell growth (29) . While stimulatory for fibroblasts and certain other mesenchymal cells, TGF-P is a growth inhibitor for most cell types (5, 30) . It is the most potent growth inhibitory polypeptide demonstrated so far (4), and it inhibits the proliferation oflymphoid cells (31, 32) , myeloid cells (30) , and epithelial cells, including hepatocytes (10) (11) (12) (13) (14) , keratinocytes (5, 6), bronchial epithelial cells (7), renal proximal tubular cells (8) , and granulosa cells (9) .
That TGF-,j could play a significant role in the control of is cleared in the first pass through an isolated perfused rat liver. We and others have shown TGF-f3 to be a potent inhibitor ofDNA synthesis in primary cultures of hepatocytes and in lines of liver epithelial cells (10) (11) (12) (13) (14) (15) . Hepatocytes in culture appear to have =2000 binding sites of a single class of TGF-P receptors that could mediate the biologic actions of TGF-,f in liver (10) . Recent studies have shown that partial hepatectomy induces an 8-fold increase in liver levels of the 2.5-kilobase mRNA for TGF-(31 (33 (38) . Thus, protease activity in the vicinity of target cells may provide a physiological mechanism of TGF-f3 activation (30) .
The mechanism by which TGF-f3 inhibits cell proliferation is unknown. In virtually all cases, the inhibitory effects of TGF-j3 are reversible, and there are no cytotoxic effects (5, 6, 30) . In the present study, the data indicate that the inhibitory effect on liver regeneration after PH was a transient one and not the result of hepatotoxicity. Although TGF-P inhibits growth factor action, it does not appear to interfere with any of the early events that follow growth factor binding to receptors. TGF-p does not alter the binding (13) . This is in contrast to the effects ofa molecule that shows structural homology to TGF-f3, Mullerian inhibiting substance, which blocks EGF tyrosine kinase activity in A-431 and liver membranes (40, 41) . A lack of effect of TGF-p on early events after growth stimulation is also suggested by our observation that TGF-,8 administered late in the G1 phase of the hepatocyte cell cycle in vivo (11 hr after PH) is inhibitory, whereas that given at the time of PH is not.
The demonstration that TGF-,8 can inhibit the early proliferative component of liver regeneration after PH has several implications for physiologic and pathologic processes in liver. Since the level of mRNA for TGF-f3 within the liver increases after PH, it is possible that this or other negative regulators of cell proliferation are as important in the control of liver growth in vivo as are growth stimulators. A paracrine mode of regulation is likely, as the increase in liver TGF-f31 mRNA appears to occur in the nonparenchymal sinusoidal cells (33) . A release from the actions of a potent growth inhibitor in combination with an increase in the concentration or action of growth stimulatory molecules could be necessary both for the striking proliferative response of liver regeneration and for the subsequent restraint of liver proliferation that prevents overgrowth. According to the general criteria outlined by Potter (42) , the short half-life and high hepatic uptake of TGF-,8 render it an ideal candidate to produce highly localized and specific actions within the liver.
TGF-f3 could also play a significant role in a number of pathologic processes in the liver such as hepatic fibrosis. Besides its inhibitory effects on hepatocyte proliferation, TGF-,B stimulates proliferation of fibroblasts (5) and deposition of extracellular matrix (30) , resulting in increased production of connective tissue (43) . The demonstration that TGF-,8 inhibits the early proliferative component of liver regeneration in vivo provides strong support for the hypothesis that TGF-,S is important in the growth and repair of liver in both normal and pathologic conditions.
